10:12
2026-10-07
ca.finance.yahoo.com
artificial-intelligence
AI companies run virtual drug trials, aim to improve success of human studies
AI startup BioinvestGPT correctly predicted the outcome of five of six high-profile drug trials, including the negative result for Novartis' del-desiran, which missed its late-stage goal in September …